Kestra Investment Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Kestra Investment Management’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$342K	Buy	+689	New	+$305K	0.01%	394
2026 Q1	–	Sell	-658	Closed	-$298K	–	512
2025 Q4	$298K	Sell	658 -87	-12%	-$37.5K	0.01%	367
2025 Q3	$292K	Sell	745 -390	-34%	-$163K	0.01%	360
2025 Q2	$529K	Buy	1,135 +538	+90%	+$248K	0.01%	366
2025 Q1	$289K	Sell	597 -134	-18%	-$62.4K	0.01%	334
2024 Q4	$294K	Sell	731 -1,584	-68%	-$734K	0.01%	303
2024 Q3	$1.08M	Buy	2,315 +516	+29%	+$248K	0.05%	117
2024 Q2	$843K	Buy	+1,799	New	+$781K	0.06%	66

Other funds holding VRTX

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Kestra Investment Management's VRTX Position: Q2 2026 in Review

Kestra Investment Management opened a new position in Vertex Pharmaceuticals (VRTX) in Q2 2026: 689 shares worth $342K. The stake represents 0.01% of the portfolio and ranks #394 among its holdings. This is a return to the name: Kestra Investment Management previously reported a position in VRTX as recently as Q4 2025.

Kestra Investment Management first reported a position in VRTX in Q2 2024 and has held it in 8 quarters since. The position peaked at $1.08M in Q3 2024. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

Kestra Investment Management held 689 shares of Vertex Pharmaceuticals worth $342K as of Q2 2026.
Vertex Pharmaceuticals was a new Kestra Investment Management position in Q2 2026.
Vertex Pharmaceuticals made up 0.01% of Kestra Investment Management's portfolio in Q2 2026, its #394 holding.
Kestra Investment Management first reported a position in Vertex Pharmaceuticals in Q2 2024 and has held it in 8 quarters since.
Kestra Investment Management's Vertex Pharmaceuticals position peaked at $1.08M in Q3 2024.
1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Kestra Investment Management's 13F filing for Q2 2026, filed 5 Aug 2026.